Latest Breaking News On - Mateon therapeutics - Page 9 : comparemela.com
Windlas Biotech, Mateon Therapeutics launch complete respiratory wellness solution
Windlas Biotech, Mateon Therapeutics launch complete respiratory wellness solution
08 March 2021 | News
Source credit: Shutterstock
Gurugram based Windlas Biotech, in partnership with Mateon Therapeutics in the US, has launched an innovative drug-device therapy PulmoHeal + ARTIHealth as a complete respiratory wellness solution.
In a first, the AI-app based platform ARTIHealth™, developed by Mateon Therapeutics will enable patients to monitor the progress of their respiratory function over time by enabling them to upload daily cough and speech recording and receiving feedback on the health of their lungs.
The platform is a self-assessment and monitoring tool that provides >90 per cent accurate feedback used for suitable self-care and remote healthcare. This is part of a long-term joint development agreement with IBM Watson Health Research and Mateon.
Vuong-trieuIbmChopra-foundationWatson-health-researchWindlas-biotechMateon-therapeuticsHealth-researchAndhra-pradeshRespiratory-wellness-solutionPulmohealCovid-19CopdWindlas Biotech, Mateon Therapeutics partner to launch lung therapy solution
February 22, 2021
×
Developed from Artemisia extract, the active component of PulmoHeal has been known to exhibit multiple pharmacological activities against inflammation, viral infections, and lung repair. Windlas Biotech Pvt. Ltd., an Indian pharmaceutical contract drug development and manufacturing organisation partnered with Mateon Therapeutics, Inc., a US-based oncology company, launched a food supplement, and telemedicine support for respiratory wellness in India.
According to the joint official release, in India, around 100 million people suffer from respiratory problems. The key challenges are the lack of cost-effective and lab-free methods for the early diagnosis of diseases.
IndiaVuong-trieuMateon-therapeutics-incWindlas-biotechMateon-therapeuticsHitesh-windlassClinical-pharmacologyPulmohealMateonCovid-19Lungs